Sign up online today & collaborate
or click here to find out more
The French National Agency for Medicines and Health Products gave Nanobiotix the green light to start a Phase I/II trial in two new cancer populations for its lead product, NBTXR3. This could lead to an increase in the commercial potential of this promising French Biotech.
Nanobiotix is a great French Biotech company, which you can discover better in our exclusive interview of its charismatic CEO Laurent Levy.
For more click here